{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T20:48:10Z","timestamp":1781210890878,"version":"3.54.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T00:00:00Z","timestamp":1636934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T00:00:00Z","timestamp":1636934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"B\u00fcrgermeisterfond der Stadt Wien"},{"name":"Association for the Promotion of Research on Arteriosclerosis, Thrombosis, and Vascular Biology"},{"name":"Ludwig Boltzmann Cluster for Cardiovascular Research"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s00392-021-01970-4","type":"journal-article","created":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T17:02:37Z","timestamp":1636995757000},"page":"343-354","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Improvement of outcome prediction of hospitalized patients with COVID-19 by a dual marker strategy using high-sensitive cardiac troponin I and copeptin"],"prefix":"10.1007","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4710-0522","authenticated-orcid":false,"given":"Christoph C.","family":"Kaufmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amro","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Kassem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias K.","family":"Freynhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"J\u00e4ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Aicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Equiluz-Bruck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander O.","family":"Spiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Vafai-Tabrizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gschwantler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Fasching","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Wojta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Giannitsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,15]]},"reference":[{"key":"1970_CR1","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1056\/NEJMe2002387","volume":"382","author":"AS Fauci","year":"2020","unstructured":"Fauci AS, Lane HC, Redfield RR (2020) Covid-19 - navigating the uncharted. N Engl J Med 382:1268\u20131269","journal-title":"N Engl J Med"},{"key":"1970_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2020-317062","author":"X Li","year":"2020","unstructured":"Li X, Guan B, Su T, Liu W, Chen M, Bin Waleed K, Guan X, Gary T, Zhu Z (2020) Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis. Heart. https:\/\/doi.org\/10.1136\/heartjnl-2020-317062","journal-title":"Heart"},{"key":"1970_CR3","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.amjcard.2020.09.060","volume":"138","author":"DT Majure","year":"2021","unstructured":"Majure DT, Gruberg L, Saba SG, Kvasnovsky C, Hirsch JS, Jauhar R (2021) Northwell Health COVID-19 research consortium. Usefulness of elevated troponin to predict death in patients with COVID-19 and myocardial injury. Am J Cardiol 138:100\u2013106","journal-title":"Am J Cardiol"},{"key":"1970_CR4","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jacc.2020.06.007","volume":"76","author":"A Lala","year":"2020","unstructured":"Lala A, Johnson KW, Januzzi JL, Russak AJ, Paranjpe I, Richter F, Zhao S, Somani S, Van Vleck T, Vaid A, Chaudhry F, De Freitas JK, Fayad ZA, Pinney SP, Levin M, Charney A, Bagiella E, Narula J, Glicksberg BS, Nadkarni G, Mancini DM, Fuster V (2020) Mount sinai COVID informatics center. Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection. J Am Coll Cardiol 76:533\u2013546","journal-title":"J Am Coll Cardiol"},{"key":"1970_CR5","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1016\/j.jacc.2020.08.069","volume":"76","author":"G Giustino","year":"2020","unstructured":"Giustino G, Croft LB, Stefanini GG, Bragato R, Silbiger JJ, Vicenzi M, Danilov T, Kukar N, Shaban N, Kini A, Camaj A, Bienstock SW, Rashed ER, Rahman K, Oates CP, Buckley S, Elbaum LS, Arkonac D, Fiter R, Singh R, Li E, Razuk V, Robinson SE, Miller M, Bier B, Donghi V, Pisaniello M, Mantovani R, Pinto G, Rota I et al (2020) Characterization of myocardial injury in patients with COVID-19. J Am Coll Cardiol 76:2043\u20132055","journal-title":"J Am Coll Cardiol"},{"key":"1970_CR6","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1515\/cclm-2014-0379","volume":"52","author":"D Bolignano","year":"2014","unstructured":"Bolignano D, Cabassi A, Fiaccadori E, Ghigo E, Pasquali R, Peracino A, Peri A, Plebani M, Santoro A, Settanni F, Zoccali C (2014) Copeptin (CTproAVP), a new tool for understanding the role of vasopressin in pathophysiology. Clin Chem Lab Med 52:1447\u20131456","journal-title":"Clin Chem Lab Med"},{"key":"1970_CR7","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1016\/j.peptides.2005.04.019","volume":"26","author":"J Struck","year":"2005","unstructured":"Struck J, Morgenthaler NG, Bergmann A (2005) Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients. Peptides 26:2500\u20132504","journal-title":"Peptides"},{"key":"1970_CR8","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.rmed.2012.06.008","volume":"106","author":"M Kolditz","year":"2012","unstructured":"Kolditz M, Halank M, Schulte-Hubbert B, Bergmann S, Albrecht S, H\u00f6ffken G (2012) Copeptin predicts clinical deterioration and persistent instability in community-acquired pneumonia. Respir Med 106:1320\u20131328","journal-title":"Respir Med"},{"key":"1970_CR9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1365-2362.2007.01762.x","volume":"37","author":"B M\u00fcller","year":"2007","unstructured":"M\u00fcller B, Morgenthaler N, Stolz D, Schuetz P, M\u00fcller C, Bingisser R, Bergmann A, Tamm M, Christ-Crain M (2007) Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections. Eur J Clin Invest 37:145\u2013152","journal-title":"Eur J Clin Invest"},{"key":"1970_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.22614","volume":"32","author":"A Koch","year":"2018","unstructured":"Koch A, Yagmur E, Hoss A, Buendgens L, Herbers U, Weiskirchen R, Koek GH, Trautwein C, Tacke F (2018) Clinical relevance of copeptin plasma levels as a biomarker of disease severity and mortality in critically ill patients. J Clin Lab Anal 32:e22614","journal-title":"J Clin Lab Anal"},{"key":"1970_CR11","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1093\/eurjhf\/hfr049","volume":"13","author":"I Tentzeris","year":"2011","unstructured":"Tentzeris I, Jarai R, Farhan S, Perkmann T, Schwarz MA, Jakl G, Wojta J, Huber K (2011) Complementary role of copeptin and high-sensitivity troponin in predicting outcome in patients with stable chronic heart failure. Eur J Heart Fail 13:726\u2013733","journal-title":"Eur J Heart Fail"},{"key":"1970_CR12","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1161\/CIRCULATIONAHA.106.685503","volume":"115","author":"SQ Khan","year":"2007","unstructured":"Khan SQ, Dhillon OS, O\u2019Brien RJ, Struck J, Quinn PA, Morgenthaler NG, Squire IB, Davies JE, Bergmann A, Ng LL (2007) C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study. Circulation 115:2103\u20132110","journal-title":"Circulation"},{"key":"1970_CR13","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00011-020-01401-6","volume":"69","author":"T Iba","year":"2020","unstructured":"Iba T, Connors JM, Levy JH (2020) The coagulopathy, endotheliopathy, and vasculitis of COVID-19. Inflamm Res 69:1181\u20131189","journal-title":"Inflamm Res"},{"key":"1970_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26870","author":"M Kulu\u00f6zt\u00fcrk","year":"2021","unstructured":"Kulu\u00f6zt\u00fcrk M, \u0130n E, Telo S, Karabulut E, Ge\u00e7kil AA (2021) Efficacy of copeptin in distinguishing COVID-19 pneumonia from community-acquired pneumonia. J Med Virol. https:\/\/doi.org\/10.1002\/jmv.26870","journal-title":"J Med Virol"},{"key":"1970_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30559-2","author":"RK Gupta","year":"2021","unstructured":"Gupta RK, Harrison EM, Ho A, Docherty AB, Knight SR, van Smeden M, Abubakar I, Lipman M, Quartagno M, Pius R, Buchan I, Carson G, Drake TM, Dunning J, Fairfield CJ, Gamble C, Green CA, Halpin S, Hardwick HE, Holden KA, Horby PW, Jackson C, Mclean KA, Merson L, Nguyen-Van-Tam JS, Norman L, Olliaro PL, Pritchard MG, Russell CD, Scott-Brown J et al (2021) Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study. Lancet Respir Med. https:\/\/doi.org\/10.1016\/S2213-2600(20)30559-2","journal-title":"Lancet Respir Med"},{"key":"1970_CR16","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13531","author":"CC Kaufmann","year":"2021","unstructured":"Kaufmann CC, Ahmed A, Kassem M, Freynhofer MK, J\u00e4ger B, Aicher G, Equiluz-Bruck S, Spiel AO, Funk G-C, Gschwantler M, Fasching P, Wojta J, Huber K (2021) Mid-regional pro-atrial natriuretic peptide independently predicts short-term mortality in COVID-19. Eur J Clin Invest. https:\/\/doi.org\/10.1111\/eci.13531","journal-title":"Eur J Clin Invest"},{"key":"1970_CR17","unstructured":"https:\/\/www.siemens-healthineers.com\/laboratory-diagnostics\/assays-by-diseases-conditions\/cardiac-assays\/cardiac-troponin-assays."},{"key":"1970_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s40885-017-0068-y","author":"B Afsar","year":"2017","unstructured":"Afsar B (2017) Pathophysiology of copeptin in kidney disease and hypertension. Clin Hypertens. https:\/\/doi.org\/10.1186\/s40885-017-0068-y","journal-title":"Clin Hypertens"},{"key":"1970_CR19","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1530\/EC-20-0197","volume":"9","author":"M Popovic","year":"2020","unstructured":"Popovic M, Ebrahimi F, Urwyler SA, Donath MY, Christ-Crain M (2020) The role of IL-1 in the regulation of copeptin in patients with metabolic syndrome. Endocr Connect 9:715\u2013723","journal-title":"Endocr Connect"},{"key":"1970_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13613-020-00798-x","volume":"11","author":"J-R Lavillegrand","year":"2021","unstructured":"Lavillegrand J-R, Garnier M, Spaeth A, Mario N, Hariri G, Pilon A, Berti E, Fieux F, Thietart S, Urbina T, Turpin M, Darrivi\u00e8re L, Fartoukh M, Verdonk F, Dumas G, Tedgui A, Guidet B, Maury E, Chantran Y, Voiriot G, Ait-Oufella H (2021) Elevated plasma IL-6 and CRP levels are associated with adverse clinical outcomes and death in critically ill SARS-CoV-2 patients: inflammatory response of SARS-CoV-2 patients. Ann Intens Care 11:9","journal-title":"Ann Intens Care"},{"key":"1970_CR21","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1186\/s13054-020-03374-8","volume":"24","author":"X Li","year":"2020","unstructured":"Li X, Liu C, Mao Z, Xiao M, Wang L, Qi S, Zhou F (2020) Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 patients: a systematic review and meta-analysis. Crit Care 24:647","journal-title":"Crit Care"},{"key":"1970_CR22","first-page":"341","volume":"29","author":"M Katan","year":"2008","unstructured":"Katan M, Morgenthaler N, Widmer I, Puder JJ, K\u00f6nig C, M\u00fcller B, Christ-Crain M (2008) Copeptin, a stable peptide derived from the vasopressin precursor, correlates with the individual stress level. Neuro Endocrinol Lett 29:341\u2013346","journal-title":"Neuro Endocrinol Lett"},{"key":"1970_CR23","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.rmed.2012.05.010","volume":"106","author":"Q Lin","year":"2012","unstructured":"Lin Q, Fu F, Chen H, Zhu B (2012) Copeptin in the assessment of acute lung injury and cardiogenic pulmonary edema. Respir Med 106:1268\u20131277","journal-title":"Respir Med"},{"key":"1970_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9113627","author":"H Waldsperger","year":"2020","unstructured":"Waldsperger H, Biener M, Stoyanov KM, Vafaie M, Katus HA, Giannitsis E, Mueller-Hennessen M (2020) Prognostic value of elevated copeptin and high-sensitivity cardiac troponin T in patients with and without acute coronary syndrome: The ConTrACS Study. J Clin Med. https:\/\/doi.org\/10.3390\/jcm9113627","journal-title":"J Clin Med"},{"key":"1970_CR25","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1183\/13993003.00857-2015","volume":"46","author":"K Hellenkamp","year":"2015","unstructured":"Hellenkamp K, Schwung J, Rossmann H, Kaeberich A, Wachter R, Hasenfu\u00df G, Konstantinides S, Lankeit M (2015) Risk stratification of normotensive pulmonary embolism: prognostic impact of copeptin. Eur Respir J Eur Respir Soc 46:1701\u20131710","journal-title":"Eur Respir J Eur Respir Soc"},{"key":"1970_CR26","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1136\/heartjnl-2011-301269","volume":"98","author":"M Potocki","year":"2012","unstructured":"Potocki M, Reichlin T, Thalmann S, Zellweger C, Twerenbold R, Reiter M, Steuer S, Bassetti S, Drexler B, Stelzig C, Freese M, Winkler K, Haaf P, Balmelli C, Hochholzer W, Osswald S, Mueller C (2012) Diagnostic and prognostic impact of copeptin and high-sensitivity cardiac troponin T in patients with pre-existing coronary artery disease and suspected acute myocardial infarction. Heart 98:558\u2013565","journal-title":"Heart"},{"key":"1970_CR27","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1080\/1354750X.2020.1833084","volume":"25","author":"E Giannitsis","year":"2020","unstructured":"Giannitsis E, Slagman A, Hamm CW, Gehrig S, Vollert JO, Huber K (2020) Copeptin combined with either non-high sensitivity or high sensitivity cardiac troponin for instant rule-out of suspected non-ST segment elevation myocardial infarction. Biomarkers 25:649\u2013658","journal-title":"Biomarkers"},{"key":"1970_CR28","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s00392-020-01712-y","volume":"110","author":"E Giannitsis","year":"2021","unstructured":"Giannitsis E, Huber K, Hamm CW, M\u00f6ckel M (2021) Instant rule-out of suspected non-ST-segment elevation myocardial infarction using high-sensitivity cardiac troponin T with Copeptin versus a single low high-sensitivity cardiac troponin T: findings from a large pooled individual data analysis on 10,329 patients. Clin Res Cardiol 110:194\u2013199","journal-title":"Clin Res Cardiol"},{"key":"1970_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-028311","volume":"9","author":"E Giannitsis","year":"2019","unstructured":"Giannitsis E, Clifford P, Slagman A, Ruedelstein R, Liebetrau C, Hamm C, Honnart D, Huber K, Vollert JO, Simonelli C, Schr\u00f6der M, Wiemer JC, Mueller-Hennessen M, Schroer H, Kastner K, M\u00f6ckel M (2019) Multicentre cross-sectional observational registry to monitor the safety of early discharge after rule-out of acute myocardial infarction by copeptin and troponin: the Pro-Core registry. BMJ Open 9:e028311","journal-title":"BMJ Open"},{"key":"1970_CR30","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1177\/2048872617710791","volume":"7","author":"C Mueller","year":"2018","unstructured":"Mueller C, M\u00f6ckel M, Giannitsis E, Huber K, Mair J, Plebani M, Thygesen K, Jaffe AS, Lindahl B (2018) ESC study group on biomarkers in cardiology of the acute cardiovascular care association. Use of copeptin for rapid rule-out of acute myocardial infarction. Eur Heart J Acute Cardiovasc Care 7:570\u2013576","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"1970_CR31","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1177\/2048872616653229","volume":"6","author":"C Mueller","year":"2017","unstructured":"Mueller C, Giannitsis E, M\u00f6ckel M, Huber K, Mair J, Plebani M, Thygesen K, Jaffe AS, Lindahl B (2017) Biomarker Study group of the ESC acute cardiovascular care association. Rapid rule out of acute myocardial infarction: novel biomarker-based strategies. Eur Heart J Acute Cardiovasc Care 6:218\u2013222","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"1970_CR32","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1093\/eurheartj\/ehu178","volume":"36","author":"M M\u00f6ckel","year":"2015","unstructured":"M\u00f6ckel M, Searle J, Hamm C, Slagman A, Blankenberg S, Huber K, Katus H, Liebetrau C, M\u00fcller C, Muller R, Peitsmeyer P, von Recum J, Tajsic M, Vollert JO, Giannitsis E (2015) Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process study. Eur Heart J 36:369\u2013376","journal-title":"Eur Heart J"},{"key":"1970_CR33","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1093\/ehjacc\/zuab009","volume":"10","author":"C Mueller","year":"2021","unstructured":"Mueller C, Giannitsis E, Jaffe AS, Huber K, Mair J, Cullen L, Hammarsten O, Mills NL, M\u00f6ckel M, Krychtiuk K, Thygesen K, Lindahl B (2021) ESC Study group on biomarkers in cardiology of the acute cardiovascular care association. Cardiovascular biomarkers in patients with COVID-19. Eur Heart J Acute Cardiovasc Care 10:310\u2013319","journal-title":"Eur Heart J Acute Cardiovasc Care"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-021-01970-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-021-01970-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-021-01970-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T18:06:17Z","timestamp":1645725977000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-021-01970-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,15]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["1970"],"URL":"https:\/\/doi.org\/10.1007\/s00392-021-01970-4","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,15]]},"assertion":[{"value":"25 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Huber reports Honoraria for lectures from AstraZeneca, Bayer, Boehringer Ingelheim, B\u00b7R\u00b7A\u00b7H\u00b7M\u00b7S Thermo Fisher, Daiichi Sankyo, Pfizer, Sanofi and The Medicines Company and has received research funding form AstraZeneca and B\u00b7R\u00b7A\u00b7H\u00b7M\u00b7S Thermo Fisher. Dr. Giannitsis reports Honoraria for lecturers from Roche Diagnostics, BRAHMS Thermo Fisher Scientific, Bayer Vital GmbH and Mitsubishi Chemical Europe, institutional research grant from Roche Diagnostics and Daiichi Sankyo, consultant for Roche Diagnostics and BRAHMS Thermo Fisher Scientific, outside the submitted work. The other authors do not have any conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Research involving human subjects complied with all relevant national regulations, institutional policies and is in accordance with the tenets of the Helsinki Declaration (as revised in 2013) and has been approved by the local ethics committee of the city of Vienna (EK 20-100-VK).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}